Narayana Hrudayalaya Submits Revised Scrutinizer Report for Demerger Approval
Narayana Hrudayalaya Limited submitted a revised scrutinizer's report to stock exchanges on April 06, 2026, correcting a minor clerical error in the original documentation. The error involved the incorrect mention of 41 shareholders attending the equity shareholders meeting instead of the correct figure of 43. The company confirmed that this purely clerical correction has no impact on the voting results or outcomes of the NCLT-convened meetings held on April 02, 2026, where the demerger scheme with NH Integrated Care Private Limited received overwhelming approval across all stakeholder categories.

*this image is generated using AI for illustrative purposes only.
Narayana Hrudayalaya Limited has submitted a revised scrutinizer's report to stock exchanges following the successful approval of its demerger scheme with NH Integrated Care Private Limited. The company filed the corrected documentation on April 06, 2026, addressing a minor clerical error in the original report submitted on April 03, 2026.
Revised Report Submission
The scrutinizer CS Manali Shah identified an inadvertent clerical error in the original report regarding the number of shareholders attending the equity shareholders meeting. The attendance figure was incorrectly mentioned as 41 instead of the correct number of 43 shareholders.
| Parameter: | Original Report | Revised Report |
|---|---|---|
| Shareholders Attending: | 41 | 43 |
| Report Date: | April 03, 2026 | April 06, 2026 |
| Impact on Results: | None | None |
Voting Results Confirmation
The company confirmed that the clerical correction has no impact on the voting results or the outcome of the NCLT-convened meetings held on April 02, 2026. All voting results for the scheme of arrangement remain unchanged with overwhelming stakeholder support.
| Meeting Category: | Participants: | Approval Rate: | Votes in Favour: |
|---|---|---|---|
| Equity Shareholders | 43 attendees | 99.9999% | 16,19,59,585 votes |
| Secured Creditors | 5 creditors | 100% | 8,38,09,44,465 votes |
| Unsecured Creditors | 10 attendees | 100% | 37,12,95,63,71 votes |
Detailed Equity Shareholders Meeting Results
The revised scrutinizer's report provides comprehensive details of the equity shareholders meeting conducted through video conferencing. The meeting achieved 79.25% participation of outstanding shares with unanimous support from promoter groups and institutional investors.
| Voting Category: | Shares Held: | Votes Polled: | Participation %: | Approval Rate: |
|---|---|---|---|---|
| Promoter Group | 12,93,08,730 | 12,93,08,730 | 100.00% | 100.00% |
| Public Institutions | 3,93,59,468 | 3,14,73,473 | 79.96% | 100.00% |
| Public Non-Institutions | 3,56,92,606 | 11,77,481 | 3.30% | 99.99% |
Regulatory Compliance and Documentation
The company ensured full compliance with regulatory requirements by submitting the revised scrutinizer's report along with comprehensive voting results and annexures. The documentation includes detailed reports for all three stakeholder categories - equity shareholders, secured creditors, and unsecured creditors.
| Document Type: | Details: |
|---|---|
| Annexure A | Voting results summary |
| Annexure B | Revised scrutinizer's report |
| Additional Reports | Secured and unsecured creditor reports |
| Submission Date | April 06, 2026 |
The successful completion of the voting process with the corrected documentation marks another step forward in the demerger proceedings, with the scheme now awaiting final NCLT sanction following the overwhelming stakeholder approval across all categories.
Historical Stock Returns for Narayana Hrudayalaya
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.65% | -0.75% | +8.85% | +0.48% | -1.79% | +343.52% |
What is the expected timeline for NCLT's final sanction of the demerger scheme following this overwhelming stakeholder approval?
How will the demerger impact Narayana Hrudayalaya's market valuation and stock performance once NH Integrated Care becomes a separate entity?
What strategic advantages does the company expect to gain from separating its healthcare operations through this demerger structure?


































